Laboratoire Osalia

What Laboratoire Osalia does

Laboratoire Osalia is a privately held French veterinary pharmaceutical laboratory founded in 2014 and headquartered at 7 boulevard Saint Denis, Paris. The company develops, manufactures, and distributes generic veterinary medications, complementary and nutraceutical products, medical devices, and fluid therapy solutions across more than 220 SKUs, manufactured 45% in France and 55% across Europe under GMP (BPF) standards compliant with the French Agence Nationale du Médicament Vétérinaire and the European Medicines Agency.

Its portfolio spans major therapeutic classes — antiparasitics, anti-inflammatories, antibiotics, anesthesia and analgesia, internal medicine — alongside proprietary branded ranges including ATOPIVET (dermatology, with Dermial® Vet hyaluronic acid matrix and Biosfeen® sphingolipid technology), KERIOX (ear and skin care, using the patented HaAg+ technology), VERSIKOR (nutraceutical based on the COV-1 Coriolus versicolor strain), EASYPILL (palatable supplements), OSALIM (vitamin/mineral supplements), and OSADIAG (rapid immunochromatographic diagnostic tests). Proprietary biochemical ingredients provide differentiation in specific dermatological and nutraceutical lines.

Osalia serves 6,500+ veterinary clinics in France as its primary B2B customer base, distributed through a nationwide field sales team of regional delegates, all major veterinary purchasing groups and wholesalers, and partner e-commerce platforms (Chronovet, Companimo, Vetostore, Vetfornut, among others). The revenue model is transactional one-time sales of medications and products at competitive generic pricing, positioning the company as an affordable, quality-assured alternative to branded veterinary pharmaceuticals. The company reports no venture or private equity funding and is led by founder Julien Rochet (Président-Directeur Général and Responsible Veterinarian). ESG commitments include the EcoTree reforestation partnership (since 2022) and Beauval Nature biodiversity partnership, recognized by the EcoVadis Gold Medal awarded in April 2026.

Name

Laboratoire Osalia

Legal name

OSALIA

Website

https://osalia.vet

Company type

Private

Founded year

2014

Operating status

Operating

Headcount range

11–50 employees

Short description

Laboratoire Osalia is a privately held French veterinary pharmaceutical laboratory, founded in 2014 and headquartered in Paris, that manufactures and distributes 220+ generic medications, nutraceuticals, medical devices, and diagnostics to 6,500+ veterinary clinics across France through field sales, wholesalers, and e-commerce.

Ownership category

akta.pro rank

Product category

Veterinary Pharmaceuticals

NAICS

Pharmaceutical Preparation Manufacturing (325412)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Livestock & Production Animal Therapeutics (Rx) (HLAMAEAB)

Keywords

• Veterinary pharmaceuticals
• Animal health products
• Generic veterinary medications
• Pet nutritional supplements
• Veterinary medical devices

Headquarters

HQ city

Paris

HQ country

France

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Generic Veterinary Medications: Sale of generic veterinary pharmaceutical products including antiparasitics, anti-inflammatories, antibiotics, anesthesia and analgesia medications, and internal medicine treatments. Products are manufactured in Europe following strict GMP standards and sold to veterinary clinics at competitive pricing to improve accessibility.
2. Nutraceutical and Complementary Products: Sale of food supplements and complementary products for pets including digestive health (EASYPILL range), dermatological care (ATOPIVET, KERIOX), joint support, urinary care, and nutritional supplements (OSALIM, VERSIKOR). Products sold through veterinary clinics and e-commerce platforms.
3. Veterinary Medical Devices: Sale of medical devices including diagnostic tests (OSADIAG rapid tests), hypodermic needles, syringes, perfusers, and accessories for veterinary use.
4. Fluid Therapy Solutions: Sale of injectable fluid therapy products including sodium chloride solutions, Ringer lactate, and glucose solutions in various formats for veterinary clinical use.

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels5 records

Core offering

Laboratoire Osalia manufactures and distributes a portfolio of 220+ generic veterinary medications (antiparasitics, anti-inflammatories, anesthesia/analgesia, antibiotics, internal medicine), complementary nutrition and dermatology products (OSALIM, VERSIKOR, ATOPIVET, EASYPILL, KERIOX), medical devices (OSADIAG rapid diagnostic tests, needles, syringes, perfusers), and injectable fluid therapy solutions (sodium chloride, Ringer lactate, glucose). All medications are produced in France and Europe under GMP compliance and sold primarily to French veterinary clinics.

Differentiator

Problem solved

Functional benefit

Brands

• OSALIM: Mineral and vitamin supplement range for dogs and cats to balance home-cooked and mixed diets.
• VERSIKOR
• ATOPIVET
• EASYPILL
• KERIOX
• OSADIAG

Products and services

• Gamme Médicaments (Generic Veterinary Medications) Generic veterinary medications covering major therapeutic classes (antiparasitics, anti-inflammatories, anesthesia and analgesia, antibiotics, internal medicine) for the majority of animal species. Produced in Europe under GMP standards defined by the French Agence Nationale du Médicament Vétérinaire and the European Medicines Agency. Sold to veterinary clinics as affordable alternatives to branded medications.
• OSALIM Mineral and vitamin supplement range (Physio+, Skin+, Digest+, Senior+) designed to balance homemade and mixed diets for dogs and cats. Produced in France and sold through veterinary clinics and partner e-commerce platforms.
• VERSIKOR Palatable nutritional supplement containing PSP (polysaccharopeptide) from the proprietary COV-1 Coriolus versicolor mushroom strain, formulated to support quality of life, weight, and appetite in dogs and cats with chronic conditions. Available in tablet (500 mg) and chew formats (250 mg for cats, 1250 mg for dogs).
• ATOPIVET Dermatological range for dogs and cats with skin sensitivities, available as an oral solution and as collars. Built on Dermial Vet hyaluronic acid matrix and Biosfeen sphingolipid ceramide precursor technology for skin barrier support in atopic dermatitis management.
• EASYPILL Wide range of palatable food supplements for cats and dogs covering dermatology, joint health, digestive health, urinary comfort, renal support, hepatic support, senior care, and stress management. Designed for easy administration and sold through veterinary clinics and partner e-commerce platforms.
• KERIOX Cosmetic and dermatological range for ear cleaning, eye hygiene, and skin care for dogs and cats. Uses the proprietary HaAg+ patented technology with antiseptic and protective properties for hygiene and protection.
• OSADIAG (Rapid Diagnostic Tests) Rapid diagnostic tests by immunochromatography for cats and dogs, including FIV/FeLV combo tests and vector-borne disease panels, intended for in-clinic veterinary use.
• Veterinary Fluid Therapy Solutions (Solutés) Injectable fluid therapy products including sodium chloride solutions, Ringer lactate, and glucose solutions in various formats intended for veterinary clinical use.
• Veterinary Medical Devices and Accessories Veterinary medical devices and accessories including hypodermic needles, syringes, perfusers, and related consumables intended for in-clinic veterinary use.

Quantifiable outcome

• Over 10 years in the veterinary pharmaceutical market with growing customer base
• +2 more outcomes

Named customers1 record

Segments2 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Two partnerships are on record, tiered core.

• EcoTreecoreStrategic or Co-development Partner · 1 January 2022Environmental partnership initiated in 2022 to support French forest development and maintenance. Osalia contributes to three forests in Brittany, Meuse, and Limousin regions. Goal of planting 1,000 trees per year (25 tonnes CO2 sequestration). Every client engagement contributes directly to carbon neutrality efforts.
• Beauval NaturecoreStrategic or Co-development PartnerBiodiversity conservation partnership with ZooParc de Beauval association. Supports over 140 conservation actions since 2009 across 5 continents with €3M annual budget. Programs include wildlife care center (Beauval Nature – Françoise Delord opened 2023), HELP Congo primate protection, ElefantAsia veterinary care in Asia, and local biodiversity studies in Centre-Val de Loire.

Scale indicators7 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Elanco Animal Health: Global animal health company following its acquisition of Bayer Animal Health and most recently Dechra. Competes with Osalia across companion animal pharma and offers a benchmark for what scaled, multi-channel vet pharma distribution looks like.
• Dechra Pharmaceuticals: Specialty veterinary pharmaceuticals company (now part of Elanco) with strong positions in companion animal endocrinology, dermatology and anti-infectives — therapeutic categories where Osalia is also active.
• Ceva Santé Animale: Large French-based animal health company with broad pharmaceutical, vaccine and companion-animal product portfolios. Competes with Osalia in the French vet-pharmacy channel but at significantly larger scale and with much wider international footprint.
• Boehringer Ingelheim Animal Health: Large multinational animal health division with broad parasiticides, vaccines and pharma portfolio. Overlaps directly with Osalia's antiparasitic and anti-infective offerings sold through French veterinary clinics.
• Zoetis: Global leader in animal health pharmaceuticals, vaccines, diagnostics and devices. Competes with Osalia across multiple therapeutic classes and represents both the benchmark and the dominant competitive threat in the French vet channel.

Direct peers

• Vetoquinol: Independent French veterinary pharmaceutical group selling Rx and non-Rx products to veterinary clinics across Europe. Comparable mid-market positioning, therapeutic breadth, and clinic-channel distribution model to Osalia.
• Dômes Pharma: French veterinary specialty pharma group (including TVM and Audevard brands) selling Rx drugs and nutraceuticals through veterinary clinics in France and Europe. Closely comparable on product mix, channel and therapeutic focus.
• Virbac: French-headquartered animal health company focused on companion animal pharmaceuticals, vaccines and diagnostics. Directly comparable to Osalia in product categories (dermatology, parasiticides, supplements) and customer base (veterinary clinics), though at much larger scale.
• Audevard: French veterinary nutraceutical and supplement laboratory (part of Dômes Pharma) targeting equine and companion animal clinics. Highly comparable to Osalia's OSALIM, VERSIKOR, EASYPILL and ATOPIVET supplement ranges.

Regional players

• MP Labo: Smaller French veterinary pharmaceutical laboratory selling generic and specialty products through French veterinary clinics. Closest scale-and-channel comparable to Osalia in the French market.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/osalia

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Laboratoire Osalia